From November 11 to 14, 2024, the 56th Düsseldorf Medical Equipment Exhibition ("MEDICA 2024") will be held at the Düsseldorf Exhibition Center in Germany.
VACURE is delighted to invite you to join us to explore the forefront of world medicine, and sincerely invites our hornable partners and friend to visit our booth 1H 39-1. At that time, VACURE will show innovative advanced diagnostic technologies and the latest solutions to discuss with you the deep understanding of clinical diagnosis and how to benefit medical professionals and patients!
About MEDICA
MEDICA is the world's largest and most authoritative comprehensive medical exhibition. It is recognized as the world's largest medical equipment exhibition and ranks first in the world's medical trade exhibition with its irreplaceable scale and influence. It is held every year in Düsseldorf, Germany, to showcase various products and services in the entire field from outpatient treatment to inpatient treatment. The exhibited products include all conventional categories of medical equipment and supplies as well as medical communication information technology, medical furniture and equipment, medical site construction technology, medical equipment management, etc.
Booth Information
Date: November 11-14
Add: Düsseldorf Exhibition Center
Booth: 1H 39-1
VACURE is conducting close exchanges and discussions with global customer partners, accelerating the strategic pace of internationalization, and opening a new chapter.
We are looking forward to your visit to 1H 39-1, MEDICA 2024!
About VACURE
VACURE is a high-tech enterprise focusing on the field of in vitro diagnostics (IVD) point-of-care testing (POCT). The company has gathered many R&D personnel (accounting for 39%) from the Provincial Thousand Talents Program. Based on self-developed patented core technologies such as microfluidic chip design, time-resolved fluorescent nanomaterials, and inkjet freeze-drying, the company has independently developed the fluorescent immunoassay quantitative detection platform LYOFIA system through a number of underlying technological innovations, iteratively upgraded the DISKFLU disc-type microfluidic immunoassay chip system, and laid out the GENFLU microfluidic molecular integrated POCT detection system to create high-performance POCT immunoassay and molecular products, and realize the self-development and production of the entire chain of raw materials, instruments and reagents. Since setting sail in 2023, the products have been exported to more than 70 countries at home and abroad.
Contact us:
Email: info@vacurebiotech.com
Tel: +86 028 85155537
For more overseas information, please follow our official website (www.vacurebiotech.com) and overseas social media accounts LinkedIn, Facebook, Twitter, Whatsapp, and exciting things are waiting for you!